CN103254183B - 阿法替尼的制备方法 - Google Patents
阿法替尼的制备方法 Download PDFInfo
- Publication number
- CN103254183B CN103254183B CN201310173504.9A CN201310173504A CN103254183B CN 103254183 B CN103254183 B CN 103254183B CN 201310173504 A CN201310173504 A CN 201310173504A CN 103254183 B CN103254183 B CN 103254183B
- Authority
- CN
- China
- Prior art keywords
- buddhist nun
- preparation
- base
- dimethylamino
- thf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (8)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173504.9A CN103254183B (zh) | 2013-05-10 | 2013-05-10 | 阿法替尼的制备方法 |
PCT/CN2014/076536 WO2014180271A1 (zh) | 2013-05-10 | 2014-04-30 | 阿法替尼及其中间体的制备方法 |
US14/957,607 US9845315B2 (en) | 2013-05-10 | 2015-12-03 | Method for preparing Afatinib and intermediate thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310173504.9A CN103254183B (zh) | 2013-05-10 | 2013-05-10 | 阿法替尼的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103254183A CN103254183A (zh) | 2013-08-21 |
CN103254183B true CN103254183B (zh) | 2015-11-11 |
Family
ID=48958447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310173504.9A Active CN103254183B (zh) | 2013-05-10 | 2013-05-10 | 阿法替尼的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103254183B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014180271A1 (zh) * | 2013-05-10 | 2014-11-13 | 苏州明锐医药科技有限公司 | 阿法替尼及其中间体的制备方法 |
CN103755688B (zh) * | 2013-12-24 | 2015-11-18 | 江苏奥赛康药业股份有限公司 | 一种阿法替尼化合物的制备方法 |
CN104478863A (zh) * | 2014-12-23 | 2015-04-01 | 康伯莱(天津)药物研发有限责任公司 | 一种阿法替尼的制备方法 |
US10550107B2 (en) | 2015-05-18 | 2020-02-04 | Msn Laboratories Private Limited | Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003094921A2 (de) * | 2002-05-11 | 2003-11-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von hemmern der egfr-vermittelten signaltransduktion zur behandlung von gutartiger prostatahyperplasie (bph)/prostatahypertrophie |
CN1481370A (zh) * | 2000-12-20 | 2004-03-10 | ���ָ��Ӣ��ķ�������Ϲ�˾ | 喹唑啉衍生物,含该化合物的药物组合物,其用途及其制备方法 |
WO2007085638A1 (en) * | 2006-01-26 | 2007-08-02 | Boehringer Ingelheim International Gmbh | Process for preparing aminocrotonylamino-substituted quinazoline derivatives |
WO2012122058A2 (en) * | 2011-03-04 | 2012-09-13 | Newgen Therapeutics, Inc. | Alkyne substituted quinazoline compound and methods of use |
-
2013
- 2013-05-10 CN CN201310173504.9A patent/CN103254183B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1481370A (zh) * | 2000-12-20 | 2004-03-10 | ���ָ��Ӣ��ķ�������Ϲ�˾ | 喹唑啉衍生物,含该化合物的药物组合物,其用途及其制备方法 |
WO2003094921A2 (de) * | 2002-05-11 | 2003-11-20 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von hemmern der egfr-vermittelten signaltransduktion zur behandlung von gutartiger prostatahyperplasie (bph)/prostatahypertrophie |
WO2007085638A1 (en) * | 2006-01-26 | 2007-08-02 | Boehringer Ingelheim International Gmbh | Process for preparing aminocrotonylamino-substituted quinazoline derivatives |
WO2012122058A2 (en) * | 2011-03-04 | 2012-09-13 | Newgen Therapeutics, Inc. | Alkyne substituted quinazoline compound and methods of use |
Non-Patent Citations (2)
Title |
---|
Irreversible Inhibition of Epidermal Growth Factor Receptor Activity by 3-Aminopropanamides;Caterina Carmi,等;《Journal of Medicinal Chemistry》;20120226;第55卷(第5期);第2251-2264页 * |
拉帕替尼的合成;季兴,等;《中国医药工业杂志》;20091110;第40卷(第11期);第801-804页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103254183A (zh) | 2013-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103254183B (zh) | 阿法替尼的制备方法 | |
CN103288808B (zh) | 一种阿法替尼的制备方法 | |
CN103242303A (zh) | 阿法替尼的制备方法 | |
CN103254182A (zh) | 一种阿法替尼的制备方法 | |
CN103373991A (zh) | 高纯度、高收率制备吡贝地尔的方法 | |
CN103265482A (zh) | 博舒替尼的制备方法 | |
CN103232380A (zh) | 一种泊马度胺关键中间体的制备方法 | |
CN103360374A (zh) | 维拉唑酮及其盐的合成方法 | |
CN105037236A (zh) | 瑞博西尼中间体及其制备方法 | |
CN103265530A (zh) | 来那替尼的制备方法 | |
CN102030707A (zh) | 布南色林中间体的制备方法 | |
CN102757350A (zh) | 厄罗替尼中间体3-氨基苯乙炔的制备方法 | |
CN104710413B (zh) | 二马来酸阿法替尼的制备方法 | |
CN103275072B (zh) | 塞卡替尼的制备方法 | |
CN103265497B (zh) | 一种替尼类抗肿瘤药合成所需中间体4-氯-6-氨基-7-羟基喹唑啉及其制备方法 | |
CN114014850A (zh) | 一种普克鲁胺中间体及其合成方法及由该中间体合成普克鲁胺的方法 | |
CN113336703A (zh) | 1,3,4,5-四取代1h-吡唑衍生物的合成 | |
CN104829470A (zh) | 一组合成伊伐布雷定的中间体化合物及其应用 | |
CN103288757B (zh) | 6-氨基-7-羟基-3,4-二氢喹唑啉-4-酮的制备方法 | |
CN101555248B (zh) | 一种多取代1,5-萘啶化合物的制备方法 | |
CN105884746A (zh) | 氟马替尼的合成方法 | |
CN104356139B (zh) | 一种氯化两面针碱的合成方法 | |
CN103467422A (zh) | 一种制备维拉唑酮中间体5-哌嗪基-2-酰基取代苯并呋喃的方法 | |
CN101851233B (zh) | 盐酸帕洛诺司琼和其前体化合物及制备 | |
CN101665483B (zh) | 一种雷尼酸锶中间体化合物ⅱ的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200513 Address after: 210000 Qinhuai Avenue 288, Yongyang Street, Lishui District, Nanjing City, Jiangsu Province Patentee after: Nanjing xunyin Seismic Technology Co., Ltd Address before: 215000 Jiangsu Province, Suzhou City Industrial Park Commercial Plaza Building 1 room 1305 Lianfeng Co-patentee before: Xu Xuenong Patentee before: SUZHOU MIRACPHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200923 Address after: 244000 Huayuan Road, Tongling, Anhui, No. 192 on the first floor Patentee after: Tongling Shangdong hi tech Innovation Co., Ltd Address before: 210000 Qinhuai Avenue 288, Yongyang Street, Lishui District, Nanjing City, Jiangsu Province Patentee before: Nanjing xunyin Seismic Technology Co.,Ltd. |